Purpose: To evaluate placental function and perfusion in a rat model of preeclampsia infused with L-nitro-arginine methyl ester (L-NAME) by dynamic contrast-enhanced (DCE) MRI using gadolinium chelates. Methods: Pregnant female Sprague-Dawley rats were fitted on embryonic day 16 (E16) with subcutaneous osmotic minipumps loaded to deliver, continuously, L-NAME (50 mg/day per rat; case group) or saline solution (control group). DCE MRI was performed on E19 using gadolinium chelates and a 4.7-T MRI apparatus for small animals. Quantitative analysis was performed using an image software program: placental blood flow (perfusion in mL/min/100 mL of placenta) and fractional volume of the maternal vascular placental compartment (ratio between the placental blood volume and the placental volume, Vb in %) were calculated by compartmental analysis. Results: A total of 176 placentas (27 rats) were analyzed by DCE MRI (97 cases and 79 controls). The model was effective, inducing intrauterine growth retardation, as there was a significant difference between the two groups for placental weight (p < 0.01), fetal weight (p = 0.019), and fetal length (p < 0.01). There was no significant difference in placental perfusion between the L-NAME and control groups (140.1 ± 74.1 vs. 148.9 ± 97.4, respectively; p = 0.496). There was a significant difference between the L-NAME and control groups for Vb (53 ± 12.9 vs. 46.7 ± 9%, respectively; p < 0.01). Conclusion: In the L-NAME preeclampsia model, placental perfusion is normal and the fractional blood volume is increased, suggesting that preeclampsia is not always expressed as a result of decreased placental perfusion. This highlights the usefulness of MRI for investigating the physiopathology of preeclampsia.

Keywords:
Placenta, Perfusion, Dynamic contrast-enhanced MRI, Preeclampsia
1.
Hutcheon JA, Lisonkova S, Joseph KS: Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol 2011; 25: 391–403.
2.
Pennington KA, Schlitt JM, Jackson DL, Schulz LC, Schust DJ: Preeclampsia: multiple approaches for a multifactorial disease. Dis Model Mech 2012; 5: 9–18.
3.
Cnossen JS, Morris RK, ter Riet G, Mol BW, van der Post JA, Coomarasamy A, et al: Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008; 178: 701–711.
4.
Chalouhi GE, Deloison B, Siauve N, Aimot S, Balvay D, Cuenod CA, et al: Dynamic contrast-enhanced magnetic resonance imaging: definitive imaging of placental function? Semin Fetal Neonatal Med 2011; 16: 22–28.
5.
Salomon LJ, Siauve N, Balvay D, Cuenod CA, Vayssettes C, Luciani A, et al: Placental perfusion MR imaging with contrast agents in a mouse model. Radiology 2005; 235: 73–80.
6.
Taillieu F, Salomon LJ, Siauve N, Clement O, Faye N, Balvay D, et al: Placental perfusion and permeability: simultaneous assessment with dual-echo contrast-enhanced MR imaging in mice. Radiology 2006; 241: 737–745.
7.
Deloison B, Siauve N, Aimot S, Balvay D, Thiam R, Cuenod C, et al: SPIO-enhanced magnetic resonance imaging study of placental perfusion in a rat model of intrauterine growth restriction. BJOG 2012; 119: 626–633.
8.
Alison M, Quibel T, Balvay D, Autret G, Bourillon C, Chalouhi GE, et al: Measurement of placental perfusion by dynamic contrast-enhanced MRI at 4.7 T. Invest Radiol 2013; 48: 535–542.
9.
McCarthy FP, Kingdom JC, Kenny LC, Walsh SK: Animal models of preeclampsia; uses and limitations. Placenta 2011; 32: 413–419.
10.
Molnár M, Sütö T, Tóth T, Hertelendy F: Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994; 170: 1458–1466.
11.
Kaya A, Boztosun A, Seckin H, Guven AS, Kucukdurmaz Z, Gulturk S, et al: The evaluation of hypoxia-inducible factor 1 in N-nitro-L-arginine methyl ester preeclampsia model of pregnant rats. J Investig Med 2011; 59: 1268–1272.
12.
Salomon LJ, Siauve N, Taillieu F, Balvay D, Vayssettes C, Frija G, et al: In vivo dynamic MRI measurement of the noradrenaline-induced reduction in placental blood flow in mice. Placenta 2006; 27: 1007–1013.
13.
Siauve N, Chalouhi GE, Deloison B, Alison M, Clement O, Ville Y, et al: Functional imaging of the human placenta with magnetic resonance. Am J Obstet Gynecol 2015; 213:S103–S114.
14.
Brix G, Bahner ML, Hoffmann U, Horvath A, Schreiber W: Regional blood flow, capillary permeability, and compartmental volumes: measurement with dynamic CT – initial experience. Radiology 1999; 210: 269–276.
15.
Aimot-Macron S, Salomon LJ, Deloison B, Thiam R, Cuenod CA, Clement O, et al: In vivo MRI assessment of placental and foetal oxygenation changes in a rat model of growth restriction using blood oxygen level-dependent (BOLD) magnetic resonance imaging. Eur Radiol 2013; 23: 1335–1342.
16.
Alison M, Chalouhi GE, Autret G, Balvay D, Thiam R, Salomon LJ, et al: Use of intravoxel incoherent motion MR imaging to assess placental perfusion in a murine model of placental insufficiency. Invest Radiol 2013; 48: 17–23.
17.
Chalouhi GE, Alison M, Deloison B, Thiam R, Autret G, Balvay D, et al: Fetoplacental oxygenation in an intrauterine growth restriction rat model by using blood oxygen level-dependent MR imaging at 4.7 T. Radiology 2013; 269: 122–129.
18.
Fantel AG, Nekahi N, Shepard TH, Cornel LM, Unis AS, Lemire RJ: The teratogenicity of Nω-nitro-L-ariginine methyl ester (L-NAME), a nitric oxide synthase inhibitor, in rats. Reprod Toxicol 1997; 11: 709–717.
19.
Drobyshevsky A, Prasad PV: Placental perfusion in uterine ischemia model as evaluated by dynamic contrast enhanced MRI. J Magn Reson Imaging 2015; 42: 666–672.
20.
Frias AE, Schabel MC, Roberts VHJ, Tudorica A, Grigsby PL, Oh KY, et al: Using dynamic contrast-enhanced MRI to quantitatively characterize maternal vascular organization in the primate placenta. Magn Reson Med 2015; 73: 1570–1578.
21.
Kording F, Forkert ND, Sedlacik J, Adam G, Hecher K, Arck P, et al: Automatic differentiation of placental perfusion compartments by time-to-peak analysis in mice. Placenta 2015; 36: 255–261.
22.
Yadav BK, Neelavalli J, Krishnamurthy U, Szalai G, Shen Y, Nayak NR, et al: A longitudinal study of placental perfusion using dynamic contrast enhanced magnetic resonance imaging in murine pregnancy. Placenta 2016; 43: 90–97.
23.
Lo JO, Schabel MC, Roberts VHJ, Wang X, Lewandowski KS, Grant KA, et al: First trimester alcohol exposure alters placental perfusion and fetal oxygen availability affecting fetal growth and development in a non-human primate model. Am J Obstet Gynecol 2017; 216: 302.e1–302.e8.
24.
Krishnamurthy U, Szalai G, Shen Y, Xu Z, Yadav BK, Tarca AL, et al: Longitudinal changes in placental magnetic resonance imaging relaxation parameter in murine pregnancy: compartmental analysis. Gynecol Obstet Invest 2016; 81: 193–201.
25.
Tarrade A, Lecarpentier E, Gil S, Morel O, Zahr N, Dahirel M, et al: Analysis of placental vascularization in a pharmacological rabbit model of IUGR induced by L-NAME, a nitric oxide synthase inhibitor. Placenta 2014; 35: 254–259.
26.
Tsukimori K, Komatsu H, Fukushima K, Kaku T, Nakano H, Wake N: Inhibition of nitric oxide synthetase at mid-gestation in rats is associated with increases in arterial pressure, serum tumor necrosis factor-α, and placental apoptosis. Am J Hypertens 2008; 21: 477–481.
27.
Yallampalli C, Izumi H, Byam-Smith M, Garfield RE: An L-arginine-nitric oxide-cyclic guanosine monophosphate system exists in the uterus and inhibits contractility during pregnancy. Am J Obstet Gynecol 1994; 170: 175–185.
28.
Helmbrecht GD, Farhat MY, Lochbaum L, Brown HE, Yadgarova KT, Eglinton GS, et al: L-arginine reverses the adverse pregnancy changes induced by nitric oxide synthase inhibition in the rat. Am J Obstet Gynecol 1996; 175: 800–805.
29.
Chen D, Wang H, Huang H, Dong M: Vascular endothelial growth factor attenuates Nω-nitro-L-arginine methyl ester-induced preeclampsia-like manifestations in rats. Clin Exp Hypertens 2008; 30: 606–615.
30.
Ma R-Q, Sun M-N, Yang Z: Inhibition of nitric oxide synthase lowers fatty acid oxidation in preeclampsia-like mice at early gestational stage. Chin Med J 2011; 124: 3141–3147.
31.
Ramesar SV, Mackraj I, Gathiram P, Moodley J: Sildenafil citrate decreases sFlt-1 and sEng in pregnant L-NAME treated Sprague-Dawley rats. Eur J Obstet Gynecol Reprod Biol 2011; 157: 136–140.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.